Alzheon

is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of Alzheimer’s disease and neurological disorders...
Read more
Alzheon President & CEO: Martin Tolar

President & CEO

Martin Tolar

CEO Approval Rating

84/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$372.3M

Alzheon Competitors

1Alector
2Denali
3Acumen
4Cassava Sciences
5ProMIS Neurosciences
6EIP Pharma
7Chondrial Therapeutics
8Annovis
9Verge Genomics
10Tetra

Trending Companies